Latest / Durham News Today | 2 Min News | The Daily News Now!
Amgen’s Stock Soars, But Ratings Lag | Durham News
Amgen’s stock soars despite a downgrade—BofA sees its future growth as shaky, while Gilead and Vertex get top marks with solid catalysts and diversified pipelines. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai. View sources & latest updates:https://sources.thednn.ai/2e894a937cdc3a3c
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.